Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.364
-0.019 (-4.84%)
Apr 29, 2026, 11:27 AM EDT - Market open

Ensysce Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Net Income
-10.18-7.99-10.61-24.17-29.08
Upgrade
Depreciation & Amortization
0.01---0
Upgrade
Other Amortization
-1.20.330.951.92
Upgrade
Loss (Gain) From Sale of Assets
----0-
Upgrade
Stock-Based Compensation
0.850.110.881.070.12
Upgrade
Other Operating Activities
00.03-0.43-1.2120.1
Upgrade
Change in Accounts Receivable
-0.3-0.030.180.16-0.44
Upgrade
Change in Accounts Payable
1.82-0.58-1.232.64-1.42
Upgrade
Change in Other Net Operating Assets
-0-0.250.112.670.56
Upgrade
Operating Cash Flow
-7.81-7.5-10.78-17.89-8.24
Upgrade
Capital Expenditures
-0.12----
Upgrade
Sale of Property, Plant & Equipment
---0-
Upgrade
Investing Cash Flow
-0.12--0-
Upgrade
Long-Term Debt Issued
--1.617.5314.38
Upgrade
Total Debt Issued
--1.617.5314.38
Upgrade
Long-Term Debt Repaid
-0.22-0.86-1.45-2-0.96
Upgrade
Net Debt Issued (Repaid)
-0.22-0.860.155.5313.42
Upgrade
Issuance of Common Stock
3.674.19.053.786.89
Upgrade
Other Financing Activities
1.316.64-0.45-0.55-
Upgrade
Financing Cash Flow
8.749.888.768.7720.31
Upgrade
Net Cash Flow
0.812.38-2.02-9.1212.07
Upgrade
Free Cash Flow
-7.93-7.5-10.78-17.89-8.24
Upgrade
Free Cash Flow Margin
-156.51%-144.00%-483.30%-708.87%-233.41%
Upgrade
Free Cash Flow Per Share
-3.10-10.75-71.42-1491.24-
Upgrade
Cash Income Tax Paid
00000
Upgrade
Levered Free Cash Flow
-4.42-4.96-7.42-11.19-14.66
Upgrade
Unlevered Free Cash Flow
-4.41-5.35-7.53-11.36-14.57
Upgrade
Change in Working Capital
1.52-0.85-0.955.48-1.3
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.